MedPath

SENSEYE, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:1

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Feasibility and ML Training Investigation of the Senseye DT for Diagnosis of Adults with PTSD

Completed
Conditions
Generalized Anxiety Disorder
PTSD
Major Depressive Disorder
First Posted Date
2023-02-08
Last Posted Date
2024-12-11
Lead Sponsor
Senseye, Inc.
Target Recruit Count
338
Registration Number
NCT05717439
Locations
🇺🇸

University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States

🇺🇸

Velocity Clinical Research, Meridian, Idaho, United States

🇺🇸

Ralph H. Johnson VA Health Care System, Charleston, South Carolina, United States

and more 2 locations

Senseye's OBCI Diagnostic Tool for PTSD

Terminated
Conditions
PTSD
First Posted Date
2022-05-12
Last Posted Date
2023-04-12
Lead Sponsor
Senseye, Inc.
Target Recruit Count
61
Registration Number
NCT05372523
Locations
🇺🇸

Olive View - UCLA Medical Center, Sylmar, California, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.